MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Hand, Foot and Mouth Disease on the Rise
A number of states are reporting an uptick in HFMD, a highly contagious viral illness that primarily affects infants and young children.
Preparing for the Hazards of Winter Weather
Winter is here and healthcare facilities must be ready for inclement weather to prevent slips and falls.
BayCare Reveals Pagidipati Children's Hospital at St. Joseph's
It is a freestanding facility scheduled to open in 2030.
Why Identity Governance Is Becoming a Facilities Management Issue
As healthcare buildings grow more connected, weak identity controls can expose HVAC, security and other critical systems to serious risk.
Habitat Health Opens South Los Angeles PACE Center
The new center strengthens the local care infrastructure, delivering integrated medical, social and in-home care.